| P50 | author | Jianchao Ying | Q87724721 |
| P2093 | author name string | Qian Wang | |
| | Kai Xu | |
| | Teng Xu | |
| | Yu Tong | |
| | Xianning Dai | |
| | Danna He | |
| P2860 | cites work | Integrated genomic characterization of endometrial carcinoma | Q28289962 |
| | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 |
| | A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion | Q33683007 |
| | A microRNA survival signature (MiSS) for advanced ovarian cancer. | Q34167137 |
| | A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. | Q34433540 |
| | Pten signaling in gliomas | Q34707865 |
| | Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution. | Q34786718 |
| | Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. | Q35011389 |
| | MicroRNAs as potential biomarkers in cancer: opportunities and challenges | Q35271157 |
| | Oxytocin increases invasive properties of endometrial cancer cells through phosphatidylinositol 3-kinase/AKT-dependent up-regulation of cyclooxygenase-1, -2, and X-linked inhibitor of apoptosis protein | Q35780407 |
| | A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies | Q35803022 |
| | clusterProfiler: an R package for comparing biological themes among gene clusters. | Q35920061 |
| | Expression Profiles of Endometrial Carcinoma by Integrative Analysis of TCGA Data | Q35960918 |
| | The emerging roles of YAP and TAZ in cancer | Q36035567 |
| | Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer | Q36471479 |
| | Novel combination of serum microRNA for detecting breast cancer in the early stage. | Q36746303 |
| | Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. | Q37160880 |
| | Control of cell proliferation pathways by microRNAs | Q37289731 |
| | PTEN level in tumor suppression: how much is too little? | Q37832338 |
| | Compromised MAPK signaling in human diseases: an update | Q38359194 |
| | The role of miRNAs in endometrial cancer | Q38600963 |
| | MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1. | Q38701614 |
| | Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative | Q38703322 |
| | JAK-STAT signaling in cancer: From cytokines to non-coding genome. | Q38878851 |
| | miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma | Q38902340 |
| | miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer | Q39484319 |
| | Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer | Q39514886 |
| | Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. | Q39907596 |
| | Micro-RNA signature of lymphovascular space involvement in type 1 endometrial cancer. | Q40414367 |
| | A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer | Q40527517 |
| | Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer | Q41024459 |
| | Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients | Q44132305 |
| | miRWalk2.0: a comprehensive atlas of microRNA-target interactions | Q46692723 |
| | An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. | Q47140946 |
| | Cancer statistics, 2018. | Q47191906 |
| | Clinical implications of PTEN loss in prostate cancer | Q49818398 |
| | LINC01088 inhibits tumorigenesis of ovarian epithelial cells by targeting miR-24-1-5p | Q49882026 |
| | C14orf28 downregulated by miR-519d contributes to oncogenicity and regulates apoptosis and EMT in colorectal cancer. | Q51028096 |
| | MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2. | Q51760093 |
| | Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma. | Q52582799 |
| | MFAP5 promotes tumor progression and bone metastasis by regulating ERK/MMP signaling pathways in breast cancer. | Q52661925 |
| | Podoplanin - an emerging cancer biomarker and therapeutic target. | Q52724361 |
| | Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumor-derived endothelial cells. | Q54596677 |
| | Prognostic value of hsa-mir-299 and hsa-mir-7706 in hepatocellular carcinoma. | Q55407446 |
| | An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target | Q56737747 |
| | MiR-374b-5p-FOXP1 feedback loop regulates cell migration, epithelial-mesenchymal transition and chemosensitivity in ovarian cancer | Q57066015 |
| | Identification of a six-gene signature with prognostic value for patients with endometrial carcinoma | Q57283034 |
| | Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin | Q58764036 |
| | Prognostic significance of p53 overexpression in endometrial cancer | Q72132770 |
| | Mutational analysis of the CTNNB1 (beta-catenin) gene in human endometrial cancer: frequent mutations at codon 34 that cause nuclear accumulation | Q73442031 |
| | Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer | Q89136555 |
| | Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer | Q91566690 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| | limma | Q112236343 |
| | DESeq2 | Q113018293 |
| | affy | Q113334509 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endometrial cancer | Q944777 |
| P577 | publication date | 2020-03-09 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Novel miRNA markers for the diagnosis and prognosis of endometrial cancer | |